Abstract
In this study, we investigate the potential driving factors that lead to the disparity in the time-series of home dwell time, aiming to provide fundamental knowledge that benefits policy-making for better mitigation strategies of future pandemics. Taking Metro Atlanta as a study case, we perform a trend-driven analysis by conducting Kmeans time-series clustering using fine-grained home dwell time records from SafeGraph, and further assess the statistical significance of sixteen demographic/socioeconomic variables from five major categories. We find that demographic/socioeconomic variables can explain the disparity in home dwell time in response to the stay-at-home order, which potentially leads to disparate exposures to the risk from the COVID-19. The results further suggest that socially disadvantaged groups are less likely to follow the order to stay at home, pointing out the extensive gaps in the effectiveness of social distancing measures exist between socially disadvantaged groups and others. Our study reveals that the long-standing inequity issue in the U.S. stands in the way of the effective implementation of social distancing measures. Policymakers need to carefully evaluate the inevitable trade-off among different groups, making sure the outcomes of their policies reflect interests of the socially disadvantaged groups.
Highlights
We perform a trend-driven analysis by conducting Kmeans time-series clustering using fine- grained home dwell time records from SafeGraph.
We find that demographic/socioeconomic variables can explain the disparity in home dwell time in response to the stay-at-home order.
The results suggest that socially disadvantaged groups are less likely to follow the order to stay at home, potentially leading to more exposures to the COVID-19.
Policymakers need to make sure the outcomes of their policies reflect the interests of the disadvantaged groups.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was funded by the Vice Chancellor for Research & Innovation of the University of Arkansas. The funders and data providers had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
zhenlong{at}sc.edu, Junyu.Lu{at}asu.edu, sicheng.wang{at}rutgers.edu, hw652{at}cornell.edu, chenbaix{at}umich.edu
Data Availability
The original data is derived from SafeGraph. The preprocessed data can be obtained upon request.
